Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
Envoy Medical Inc. (COCHW)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/28/2025: COCHW (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit -70% | Avg. Invested days 25 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 08/28/2025 |
Key Highlights
Company Size ETF | Market Capitalization 0 USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta 2.27 | 52 Weeks Range 0.03 - 0.10 | Updated Date 06/28/2025 |
52 Weeks Range 0.03 - 0.10 | Updated Date 06/28/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) - |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) -11102.17% |
Management Effectiveness
Return on Assets (TTM) -129.07% | Return on Equity (TTM) - |
Valuation
Trailing PE - | Forward PE - | Enterprise Value - | Price to Sales(TTM) - |
Enterprise Value - | Price to Sales(TTM) - | ||
Enterprise Value to Revenue - | Enterprise Value to EBITDA - | Shares Outstanding - | Shares Floating 10658404 |
Shares Outstanding - | Shares Floating 10658404 | ||
Percent Insiders - | Percent Institutions - |
Upturn AI SWOT
Envoy Medical Inc.
Company Overview
History and Background
Envoy Medical Inc. is a hearing health company focused on developing innovative implantable devices. Founded in 1995, the company has focused on designing and manufacturing fully implantable hearing solutions to address sensorineural hearing loss.
Core Business Areas
- Esteem Fully Implantable Hearing Device: Envoy Medical's core product is the Esteem, a fully implantable active middle ear implant (AMEI) designed to restore natural hearing. It directly stimulates the ossicular chain, bypassing the outer and middle ear.
Leadership and Structure
Envoy Medical Inc. is led by a management team including a CEO, CFO, and heads of R&D, manufacturing, and sales/marketing. The organizational structure is hierarchical, common for medical device companies with significant R&D and regulatory requirements.
Top Products and Market Share
Key Offerings
- Esteem Fully Implantable Hearing Device: The Esteem is Envoy Medical's primary product. It's designed to restore natural hearing through direct ossicular chain stimulation. Market share information is not readily available, but Esteem competes with traditional hearing aids and cochlear implants. Competitors include Cochlear Limited (COCH.AX), Sonova (SONVX.SW), and Demant A/S (DEMANT.CO).
Market Dynamics
Industry Overview
The hearing aid and hearing implant market is growing, driven by an aging population, increased awareness of hearing loss, and technological advancements. The market is competitive, with established players and emerging companies developing innovative solutions.
Positioning
Envoy Medical is positioned as a provider of fully implantable hearing solutions, offering a unique alternative to traditional hearing aids. Their competitive advantage lies in the discreet nature and potential for more natural sound quality provided by Esteem.
Total Addressable Market (TAM)
The global hearing aids market is projected to reach USD 14.68 billion by 2030. Envoy Medical, focusing on the fully implantable segment, targets a specific niche within this TAM. Their position is to capture a substantial portion of the premium fully implantable hearing device market.
Upturn SWOT Analysis
Strengths
- Fully implantable technology
- Potential for natural sound quality
- Discreet design
- Focus on unmet needs in hearing loss
Weaknesses
- Limited market share
- High cost of device and surgery
- Dependence on a single product (Esteem)
- Complex surgical procedure
Opportunities
- Expanding indications for Esteem
- Geographic expansion
- Partnerships with audiologists and ENTs
- Development of next-generation implantable devices
Threats
- Competition from established hearing aid manufacturers
- Technological advancements in non-implantable solutions
- Reimbursement challenges
- Regulatory hurdles
Competitors and Market Share
Key Competitors
- COCH.AX
- SONVX.SW
- DEMANT.CO
Competitive Landscape
Envoy Medical's advantage lies in its fully implantable design. Its disadvantages are related to the high cost of the device, the complexity of the surgical procedure, and the presence of much larger, more established competitors.
Growth Trajectory and Initiatives
Historical Growth: Historical growth data is limited due to its historical status as a privately held company.
Future Projections: Future growth projections depend on the successful commercialization of the Esteem device and expansion into new markets. Analyst estimates unavailable.
Recent Initiatives: Recent initiatives include securing regulatory approvals for the Esteem device and expanding its sales and marketing efforts.
Summary
Envoy Medical is a medical device company focused on implantable hearing solutions. The company's key offering, Esteem, targets a niche market. While its fully implantable design offers a competitive advantage, Envoy faces challenges related to market share, cost, and competition from larger players. The growth of the company will depend on commercial success and innovation.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company website
- Industry reports
- Market research reports
- Competitor information
Disclaimers:
This analysis is based on publicly available information and general market knowledge. Market share data are estimated and may not reflect precise figures. Investment decisions should be based on thorough due diligence and professional advice.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Envoy Medical Inc.
Exchange NASDAQ | Headquaters White Bear Lake, MN, United States | ||
IPO Launch date 2021-04-23 | CEO & Director Mr. Brent T. Lucas Esq. | ||
Sector Healthcare | Industry Medical Devices | Full time employees 42 | Website https://www.envoymedical.com |
Full time employees 42 | Website https://www.envoymedical.com | ||
Envoy Medical, Inc., a hearing health company, focuses on providing medical technologies across the hearing loss spectrum. The company's medical technologies are designed to shift the paradigm within the hearing industry and bring providers and patients the hearing devices desire. It offers personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.